跳至主要内容
临床试验/JPRN-jRCT2080221109
JPRN-jRCT2080221109未知3 期

A placebo-controlled, parallel group study of HTU-520 in patients with onychomycosis.

Hisamitsu Pharmaceutical Co., Inc.0 个研究点开始时间: 2010年5月24日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 79age old(—)
性别
All

入选标准

  • Patients with involvement of nail
  • - Patients who were found to have dermatophytosis of nail by direct microscopy
  • - Patients in whom the dermatophyte infection of nail was identified

排除标准

  • - Patients who used oral or injectable antifungal drugs within 36 weeks before informed consent was obtained
  • - Patients who used topical antifungal drugs on the area to be examined or the surrounding area up to the distal joint within 4 weeks before informed consent was obtained
  • - Patients who used terbinafine hydrochloride-containing topical antifungal drugs within 12 weeks before informed consent was obtained

研究者

相似试验